Treatment of Liver Fibrosis after Hepatitis B with TCM Combined with NAs Evaluated by Noninvasive Diagnostic Methods: A Retrospective Study

Table 2

Comparison of liver function indexes between the two groups before and after the treatment [M (p25–p75),  ± s].

	Treatments	ALB	ALT (U/L)	AST (U/L)	TBIL (μmol/L)
TCM users	Before	43.35 ± 4.92	36.92 ± 19.08	37.00 (28.00–50.75)	16.50 (12.50–21.78)
	After	43.73 ± 3.73	25.83 ± 13.10	25.00 (21.25–31.75)^△	15.70 (12.50–21.83)^△
TCM nonusers	Before	43.05 ± 5.25	34.94 ± 14.76	37.50 (28.00–49.00)	16.10 (12.48–22.25)
	After	42.25 ± 4.54	27.88 ± 13.62	29.00 (24.00–38.25)	18.25 (14.60–22.18)

Note. Compared with that before treatment in this group, ; compared with the TCM nonusers after treatment, ^△.